23.10.2012 Views

SYMPOSIA

SYMPOSIA

SYMPOSIA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Poster Presentations<br />

[PP-046] Ref. No: 240<br />

Influence of polymorphism of the norepinephrine transporter gene (SLC6A2) and<br />

alpha-2 adrenergic receptor gene (ADRA2A) on regional cerebral blood flow<br />

in a Korean ADHD sample: a preliminary study<br />

Younghui Yang 1 , Jaewon Kim 2 , Boongnyun Kim 2 , Minsup Shin 2 , Soochurl Cho 2<br />

1 Department of Psychiatry, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea<br />

2 Division of Child and Adolescent Psychiatry, Seoul National University Hospital, Seoul, Republic of Korea<br />

E-mail: nauyoung@gmail.com<br />

Some genes related to the noradrenergic system have been investigated as candidate genes in Attention Deficit Hyperactivity Disorder<br />

(ADHD). Through functional brain imaging studies, it has been reported that brain areas such as the prefrontal cortex (PFC), dorsal<br />

anterior cingulate cortex, and striatum show abnormal findings in ADHD patients. We have investigated whether there was an association<br />

between polymorphism of the noradrenergic system related genes (SLC6A2 and ADRA2A) and regional cerebral blood flow (rCBF) in a<br />

Korean ADHD sample.<br />

Methods: A total of thirty-six children (31 boys and 5 girls, mean age: 8.9 (± 1.84) years) participated in this study. Subjects were recruited<br />

from the outpatient’s clinic of child and adolescent psychiatry in the Seoul National University Hospital. The diagnosis of ADHD was made<br />

based on the DSM-IV-TR. All patients were drug naïve at the time of image acquisition. Genotyping of SLC6A2 (G1287A, -3081(A/T)) and<br />

ADRA2A (Dral, Mspl) was done. SPM8 (Statistical parametric mapping 8) was used to compare images between the two groups divided<br />

by each genotype.<br />

Results: Children with the G/A and A/A genotypes at the SLC6A2 G1287A polymorphism showed decreased rCBF in the right inferior<br />

temporal gyrus and the left middle temporal gyrus compared to children with G/G genotype (uncorrected p-value< 0.001). In ADRA2A<br />

Mspl polymorphism, children with the C/G and C/C genotypes showed increased rCBF in the left striatum and the left cingulate gyrus and<br />

decreased rCBF in the left cerebellar vermis compared to children with G/G genotype.<br />

There were no significant rCBF alterations across genotypes in the SLC6A2 -3081(A/T) and ADRA2A Mspl genes.<br />

Conclusion: This study showed that the noradrenergic system related genes might be associated with functional brain abnormalities in<br />

children with ADHD.<br />

Key words: ADHD, neuroimaging, SLC6A2, ADRA2A<br />

Bulletin of Clinical Psychopharmacology 2011;21(Suppl. 2):S148<br />

[PP-047] Ref. No: 129<br />

Do we need specialist clinics to monitor metabolic side effects on chronic<br />

bipolar patients in Treatment? – Audit of management of bipolar disorder against<br />

NICE guidelines in South Staffordshire NHS Trust, UK<br />

Fiesal Jan, Vanathi Kennedy<br />

Foundation House, St. Georges’ Hospital, Corporation Street, ST16 3AG, Stafford<br />

E-mail: khalidnoma@hotmail.com<br />

Objective: To highlight the pharmacological management of patients with Bipolar Affective Disorder and to evaluate whether the<br />

management meets the current standards as set up by recognised guidelines, especially those underlined by NICE guidelines.<br />

Method: The audit data were collected from a patient population from the West patch of South Staffordshire and focussed on inpatients<br />

from the 2 adult units based at Stafford and a psychiatric ICU. It also included a minimum of 5 patients of both genders from all the<br />

community teams. The selection was random and not based on severity or duration of the disorder, co-morbidity or other accompanying<br />

diagnoses, for e.g, Personality disorder.<br />

The audit tool was devised by the clinical audit coordinator in conjunction with clinicians.<br />

Results: Twenty of twenty-eight 28 patients (72%) were on mood stabilizers, either lithium or sodium valproate, with sodium valproate<br />

the more preferred drug.<br />

Twelve of twenty-eight (43%) were on antipsychotics. Three of seven (43%) patients, who did not respond to combination treatment,<br />

were started on lamotrigine.<br />

In 21/22 (95%) of the patients, antidepressants were stopped.<br />

S148 Bulletin of Clinical Psychopharmacology, Vol: 21, Supplement: 2, 2011 - www.psikofarmakoloji.org

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!